Earnings4594BrightPath Biotherapeutics Co.,Ltd.
Brightpath Biotherapeutics Reports Earnings Results
TOKYO, May 14 (Pulse News Wire) – Brightpath Biotherapeutics Co., Ltd. (4594.T) reported non-consolidated results for fiscal year 2026 ending March. Revenue was ¥2.6 billion. operating profit was ¥2,3
TOKYO, May 14 (Pulse News Wire) – Brightpath Biotherapeutics Co., Ltd. (4594.T) reported non-consolidated results for fiscal year 2026 ending March.
Revenue was ¥2.6 billion. operating profit was ¥2,368 million (+90.1%).
Net profit was ¥1,304 million. Total assets stood at ¥2.6 billion with an equity ratio of 90.1%.
Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥0M | -92.6% |
| Operating profit | ¥-1,295M | n/a |
| Net profit | ¥-1,304M | n/a |
Next period forecast
Revenue
¥0M
n/aOp. profit
¥-1,965M
n/aNet profit
¥-1,949M
n/aSource: TDNet filing · Figures in millions of yen
End of article